Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

The effect of hepatic insufficiency on the safety and pharmacokinetics of paricalcitol (Zemplar).

Carr RA, André AK, Chen P, Grabowski BA, Chang MS, Locke CS, Williams LA, Chojkier M.

Nephron Clin Pract. 2006;103(3):c100-5. Epub 2006 Mar 13.

PMID:
16534233
2.

Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies.

Ryan CW, Vogelzang NJ, Vokes EE, Kindler HL, Undevia SD, Humerickhouse R, André AK, Wang Q, Carr RA, Ratain MJ.

Clin Cancer Res. 2004 Jul 1;10(13):4406-11.

Supplemental Content

Loading ...
Support Center